Mirati Therapeutics reported $-173561000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Amgen AMGN:US USD 1.62B 527M
Astellas Pharma 4503:JP JPY 71.62B 46.81B
AstraZeneca AZN:LN USD 1.64B 1.28B
Bayer BAYN:GR EUR 546M 844M
Biocryst Pharmaceuticals BCRX:US USD -42520000 16.34M
Bluebird Bio BLUE:US USD -76520000 23.62M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Eisai 4523:JP JPY 3.57B 23.33B
Eli Lilly And LLY:US USD 1.94B 486M
Exelixis EXEL:US USD 73.21M 2.54M
Gilead Sciences GILD:US USD 1.64B 149M
GlaxoSmithKline GSK:LN GBP 1.5B 8.82B
Johnson & Johnson JNJ:US USD 3.52B 938M
Merk MRK:US USD 3.02B 231M
Moderna Inc MRNA:US USD 1.04B 1.15B
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Novartis NOVN:VX USD 1.57B 121M
Pfizer PFE:US USD 5B 3.61B
Roche Holding ROG:VX 8.53B 2.4B
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Seattle Genetics SGEN:US USD -190816000 55.99M
Takeda 4502:JP JPY 119.13B 57.39B
Ultragenyx Pharmaceutical RARE:US USD -245106000 86.94M
YTE INCY:US USD 112.78M 48.66M